TG Therapeutics, Inc. (TGTX) Social Stream
Tg Therapeutics Inc (TGTX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering TGTX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 6 | $84 | $54 | $65 | $10.08 | 544.84% |
| 2021-11-10 | 6 | $84 | $54 | $64.333 | $10.08 | 538.22% |
| 2021-12-13 | 7 | $75 | $36 | $53.714 | $10.08 | 432.88% |
| 2022-01-24 | 7 | $70 | $36 | $53 | $10.08 | 425.79% |
| 2022-01-28 | 7 | $68 | $36 | $52.714 | $10.08 | 422.96% |
| 2022-02-15 | 6 | $68 | $36 | $50.285 | $10.08 | 398.86% |
| 2022-02-25 | 6 | $68 | $35 | $48.285 | $10.08 | 379.02% |
| 2022-03-02 | 7 | $68 | $35 | $45.666 | $10.08 | 353.04% |
| 2022-03-11 | 7 | $68 | $35 | $44.857 | $10.08 | 345.01% |
The Trend in the Analyst Price Target
Over the past 22 months, TGTX's average price target has gone up $6.36.
Over the past 49 weeks, TGTX's average upside potential has been 299.52%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-24 | 7 | 70 | 36 | 53.000 | 14.46 | 266.53% |
| 2022-02-23 | 6 | 68 | 35 | 48.285 | 9.43 | 412.04% |
| 2022-02-25 | 6 | 68 | 35 | 48.285 | 9.90 | 387.73% |
| 2022-03-02 | 7 | 68 | 35 | 46.857 | 10.33 | 353.6% |
| 2022-03-02 | 7 | 68 | 35 | 48.285 | 10.33 | 367.42% |
TGTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 7 | 0 | 0 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 90 days, TGTX's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, Tg Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 1139.78% of them.
- To contextualize these metrics, consider that out of all US stocks, Tg Therapeutics Inc's variance in analysts' estimates is lower than -824.84% of them.
- In the context of Pharmaceutical Products stocks, Tg Therapeutics Inc's average analyst price target is greater than 839.46% of them.
- TGTX has a greater number of analysts covering the stock than 670.17% of Pharmaceutical Products stocks.
Stocks similar to Tg Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are TBPH, TARO, and SUPN.
What is the outlook for TGTX? Use POWR Ratings for clearer insight into price direction.